Pharmacovigilance World 2021
Pharmacovigilance World 2021 Virtual conference to be held on 23 - 24 November 2021 will provide a platform for the participants to discuss, share and stay updated with the present state of affairs in Pharmacovigilance and Drug Safety, and contribute to public health.
With the augmented incidence of diseases, and the non-medical use of prescription drugs, the incidence of drug abuse has increased enormously in recent years, which is apparent with the excess documentation of adversities and drug toxicities. In this context, the drug safety and pharmacovigilance has emerged as a dynamic clinical and scientific discipline to provide adequate information and ensure health safety by the joint interaction of doctors and patients in choosing appropriate treatment method and drug.
The Pharmacovigilance World 2021 conference will provide a platform for the participants to discuss, share and stay updated with the present state of affairs in Pharmacovigilance and Drug Safety, and contribute to public health. It will also allow all its participants to interact with the experts, discuss the various developments, challenges faced and innovations in the field. Our Pharmacovigilance conferences are known for bringing world-class leaders together to connect, learn and network. The conference will bring forth the participants and the representatives from various fields of pharmacovigilance and drug safety under a common umbrella and will provide them with an opportunity to network with various industry professionals including pharmaceuticals, biologics, devices, CROs and PV service providers.
KEY HIGHLIGHTS:
- Pharmacovigilance and globalization
- Pharmacovigilance in a pandemic world
- Women and child health care medicines and pharmacovigilance
- Patient-centric approaches in PV
- Pharmacovigilance legislation and regulations
- Harmonization and pharmacovigilance
- Advanced therapeutic techniques and pharmacovigilance
- Pharmacovigilance and data management and eudravigilance
- Post-marketing surveillance in pharmacovigilance
- PV regulations and challenges
- Benefit-risk management strategies
- Risk management and minimization
- Adverse drug reactions reporting
- Signal detection and post-authorization safety
- Good Pharmacovigilance Practices
- Innovative approaches to drug safety
- Strategies to improve PV
- Real-World Evidence in PV
- Big data and AI in pharmacovigilance
- Pharmacovigilance Monitoring and automation in Social media
- Other emerging technologies in PV
